362.52

0.33% -1.21

After Hours: 362.43 -0.09 -0.02%

Bio Rad Laboratories Inc (BIO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Bio Rad Laboratories Inc stock is traded at $362.52, with a volume of 240.44K. It is down -0.33% in the last 24 hours and down -1.64% over the past month. Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Previous Close:

$363.73

Open:

$367.86

24h Volume:

240.44K

Relative Volume:

1.11

Market Cap:

$9.69B

Revenue:

$2.59B

Net Income/Loss:

$168.80M

P/E Ratio:

59.68

EPS:

6.0748

Net Cash Flow:

$357.20M

1W Performance:

-1.47%

1M Performance:

-1.64%

6M Performance:

+24.05%

1Y Performance:

+18.84%

1-Day Range:

$361.26

$371.07

1-Week Range:

$353.97

$372.59

52-Week Range:

$236.73

$396.23

Bio Rad Laboratories Inc Stock (BIO) Company Profile

Name

Bio Rad Laboratories Inc

Sector

Healthcare (1051)

Industry

Medical Devices (143)

Phone

(510) 724-7000

Address

1000 ALFRED NOBEL DRIVE, HERCULES

Employee

7,450

Twitter

@BioRadLifeSci

Next Earnings Date

2026-11-04

Latest SEC Filings

BIO's Discussions on Twitter

Compare BIO vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BIO Bio Rad Laboratories Inc	362.52	9.69B	2.59B	168.80M	357.20M	6.0748
ABT Abbott Laboratories	102.98	178.19B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	94.22	120.52B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	281.63	108.03B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.01	62.32B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.46	49.84B	6.30B	1.07B	1.09B	1.8406

Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-15-26	Resumed	RBC Capital Mkts	Outperform
Apr-07-26	Downgrade	Citigroup	Buy → Neutral
Oct-01-24	Upgrade	Citigroup	Neutral → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jun-03-24	Resumed	Jefferies	Hold
Apr-03-24	Downgrade	Citigroup	Buy → Neutral
Dec-07-23	Initiated	UBS	Buy
Jun-16-23	Initiated	Wells Fargo	Overweight
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Jan-28-22	Reiterated	Citigroup	Buy
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Buy
Oct-17-18	Initiated	Goldman	Buy
Sep-20-18	Initiated	Morgan Stanley	Equal-Weight
Feb-16-18	Downgrade	CL King	Buy → Neutral
Jul-13-17	Initiated	Wells Fargo	Outperform
Jun-28-17	Upgrade	Deutsche Bank	Hold → Buy
Jan-18-17	Initiated	Deutsche Bank	Hold
Oct-13-16	Initiated	CL King	Buy
May-06-15	Reiterated	Jefferies	Buy
Dec-18-09	Initiated	Maxim Group	Buy
Nov-06-09	Initiated	Jefferies & Co	Buy
Jul-17-09	Initiated	Soleil	Buy
Sep-26-07	Initiated	Banc of America Sec	Buy
Feb-23-07	Downgrade	Robert W. Baird	Outperform → Neutral

View All

Bio Rad Laboratories Inc Stock (BIO) Latest News

Oct 06, 2026

Neogen (NEOG) Q1 Earnings and Revenues Beat Estimates - Zacks Investment Research

Oct 06, 2026

Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.

Oct 06, 2026

Bio-Rad Reports Second-Quarter 2026 Financial Results - Investing News Network

Oct 06, 2026

Oct 05, 2026

Europe Point of Care Diagnostics Market Size and Forecast, 20212031 | Market to Reach US$21.4 Billion by 2031 as Rapid Testing and Molecular Innovation Drive 13.4% CAGR - GlobeNewswire Inc.

Oct 05, 2026

Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.

Oct 05, 2026

Magnetic Beads MarketGlobal Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 Billion - GlobeNewswire Inc.

Oct 05, 2026

Sep 30, 2026

North America Non-Viral Transfection Reagents Market Forecast to 2035 | Cell and Gene Therapy Demand Drives 8.5% CAGR and a USD 0.70 Billion Opportunity - GlobeNewswire Inc.

Sep 30, 2026

Sep 29, 2026

Bio-Rad Laboratories, Inc. Class A Revenue Breakdown – HAN:BUWA - tradingview.com

Sep 29, 2026

Bio-Rad Laboratories Inc Stock Intrinsic Values | HAM:BUWA - gurufocus.com

Sep 29, 2026

Bio-Rad Laboratories Inc Stock Baskets - gurufocus.com

Sep 29, 2026

Sep 28, 2026

Veterinary Diagnostics Market Size to Soar to USD 30.78 Billion by 2035 at a CAGR of 10.1%SNS Insider - GlobeNewswire Inc.

Sep 28, 2026

Global Therapeutic Drug Monitoring Consumables Market Forecast, 2026-2032AI-Enabled Automation and Integrated Lab Workflows Drive 8.22% CAGR, Lifting the Market to USD 586.85 Million by 2032 - GlobeNewswire Inc.

Sep 28, 2026

Weekly Recap: Bio-Rad growth and margin plan and digital PCR expansion - TradingView

Sep 28, 2026

Sep 24, 2026